Kami S. Komrokji, MD, is a clinical investigator at H. Lee Moffitt Cancer Center. His research focus is on phase I and II clinical trials in Myelodysplastic syndromes (MDS) and acute myeloid leukemia. He is the lead clinical investigator for the MDS Program at the Cancer Center. He has conducted several translational clinical trials working with our basic scientists. He has also developed the MDS database, which is one of the largest is the world. Finally he serves as the Moffitt Cancer Center PI for the MDS Clinical Consortium, which is an agreement between 6 largest MDS Program in the country for conducting clinical trials in MDS. He serves as a member on the MDS NCCN committee and on the NIH MDS natural history study committee. His work in the field of MDS, specifically conducting clinical trials and outcome research, is well recognized internationally and I have collaborated with all of the major MDS programs worldwide.